Ar-Ex Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.75 M
as on 05-07-2024
- Paid Up Capital ₹ 2.45 M
as on 05-07-2024
- Company Age 68 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.51 Cr
as on 05-07-2024
- Satisfied Charges ₹ 1.84 Cr
as on 05-07-2024
- Revenue 36.57%
(FY 2022)
- Profit -34.11%
(FY 2022)
- Ebitda -142.05%
(FY 2022)
- Net Worth 44.39%
(FY 2022)
- Total Assets -0.59%
(FY 2022)
About Ar-Ex Laboratories
The Corporate was formerly known as Ar-Ex Laboratories Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.75 M and a paid-up capital of Rs 2.45 M.
The company currently has active open charges totaling ₹7.51 Cr. The company has closed loans amounting to ₹1.84 Cr, as per Ministry of Corporate Affairs (MCA) records.
Satish Gunjikar, Ajit Gunjikar, Nitin Mangaonkar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239MH1956PTC009736
- Company No.
009736
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 1956
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ar-Ex Laboratories?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Gunjikar  | Managing Director | 01-Aug-1989 | Current |
| Ajit Gunjikar | Managing Director | 30-Jun-1982 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nitin Mangaonkar | Whole-Time Director | 01-Feb-2005 | Current |
| Sudha Gunjikar | Whole-Time Director | 30-Jun-1982 | Current |
Financial Performance of Ar-Ex Laboratories.
Ar-Ex Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 36.57% increase. The company also saw a substantial fall in profitability, with a 34.11% decrease in profit. The company's net worth Soared by an impressive increase of 44.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ar-Ex Laboratories?
In 2022, Ar-Ex Laboratories had a promoter holding of 97.94% and a public holding of 2.06%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bioxera Pharma Private LimitedActive 19 years 2 monthsSatish Gunjikar, Ajit Gunjikar and 2 more are mutual person
Ar-Ex Specialities Private LimitedActive 1 year 11 monthsSatish Gunjikar and Ajit Gunjikar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Saraswat Co-Operative Bank Ltd Creation Date: 19 Mar 2012 | ₹2.50 M | Open |
The Saraswat Co-Operative Bank Ltd Creation Date: 09 Mar 2012 | ₹2.50 M | Open |
The Saraswat Co-Op Bank Ltd Creation Date: 29 Mar 2006 | ₹2.20 Cr | Open |
How Many Employees Work at Ar-Ex Laboratories?
Ar-Ex Laboratories has a workforce of 314 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ar-Ex Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ar-Ex Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
